Hints and tips:
...However F/m argues that the funds, like all ETFs, are largely off limits to investors saving for their retirement in 401(k) pension plans, a key market for bonds....
...Tony Blair to N.F.L star Tom Brady and his supermodel wife Giselle Bundchen....
...Increasing barriers to achieving financial security have led a younger generation of investors to say, “F@$K it”....
...Its co-founder and president John Zimmer told Bloomberg that airport rides, which were up threefold compared with a year earlier, coupled with a rise in weekend and evening trips, were positive signs that...
...The supervoting class B shares held by Mr Green and Mr Zimmer would convert to regular shares if their collective class B holdings fall below 20 per cent of their stakes at the time of the IPO....
...And unlike Facebook’s Mark Zuckerberg, the Lyft founders have not handed themselves majority control of the company while holding less than a fifth of the economic risk....
...At a price of $68 per share, Lyft’s two co-founders, Logan Green and John Zimmer, would see the values of their stakes rise to $569m and $393m respectively....
...Alphabet’s holding will be worth $924m....
...Currency fluctuations will also pose a challenge. “We believe that for Asia, partnering is the smart international expansion strategy,” said John Zimmer, co-founder and president of Lyft....
...Continued deal activity lifted shares of several device makers following Zimmer Holdings’ purchase of rival Biomet for $13.4bn....
...My holding company has 20 per cent margins to support. C: Kazakhstan? B: (icily) We don’t use the K word here....
...Among the latest deals, Bank of China is involved in a $1.4bn syndicated loan to Zimmer Holdings, the medical device company, and Bank of East Asia is part of a $575m loan syndication to Constellation Brands...
...Jude, Boston Scientific) underperforming badly while orthopaedic specialists (Stryker, Smith & Nephew, and Zimmer) have fared better....
...The list of realistic bidders for S&N is limited to a handful of US groups: Biomet, Johnson & Johnson, Zimmer and Stryker....
...On paper, a combined Biomet and Smith & Nephew makes perfect sense – the latter tried hard to buy the US group back in 2006....
...The group echoed comments from rivals Stryker, Zimmer and Johnson & Johnson, who have also cited concerns that orthopaedic markets may be slowing....
...One theory was that Biomet, its US rival, may be in the early stages of investigating a takeover approach....
...Zimmer Holdings, the maker of surgical products, was one of the S&P 500’s best performers as it gained 0.1 per cent to $54.60. The stock was raised to “buy” from “neutral” at Goldman Sachs on Tuesday....
...Chip designer Arm Holdings gained 3.2 per cent to 372p, bouncing back from profit-taking in the wake of Tuesday’s in-line quarterly results....
...Orthopaedics group Smith & Nephew faded 2.2 per cent to 673p after US peer Zimmer reported slowing sales for knee implants....
...It also questioned whether any company looking to enter the orthopaedics sector would buy S&N, given that the UK group is trading at a premium to market leaders Zimmer and Stryker....
...Zimmer said it would calculate the basis of the payments in a fair way, as part of a procedure for putting all its contracts with surgeons on a new footing....
...S&N’s hip resurfacing system would fill a gap for Zimmer, which last month delayed its rival product....
...S&N and three other device makers – Zimmer, Biomet and Johnson & Johnson – paid out a combined $311m to settle an investigation carried out by the US Attorney for the District of New Jersey....
...surgery available today – far more than an alternative to a Zimmer Frame....
International Edition